δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling

Documenti analoghi

• Anti‐Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells
  di: Esraa A. Aidy, et al.
  Pubblicazione: (2026)
• Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS ‐Mediated Signaling Pathways in MDA ‐ MB ‐231 Breast Cancer Cells
  di: Wen‐Shuang Hou, et al.
  Pubblicazione: (2025)
• Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers
  di: Aamir Mehmood, et al.
  Pubblicazione: (2024)
• Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis
  di: Yun‐Yi Chen, et al.
  Pubblicazione: (2025)
• Bruceine A Suppresses Triple‐Negative Breast Cancer Growth and Metastasis by Inducing GPX4 ‐Dependent Ferroptosis via Ubiquitin–Proteasome‐Mediated Degradation
  di: Hengguan Cui, et al.
  Pubblicazione: (2026)